Corrigendum to: Deficiency of NG2+ Cells Contributes to the Susceptibility of Stroke-Prone Spontaneously Hypertensive Rats: NG2,+ Cells in SHR-SP (CNS Neuroscience & Therapeutics, (2011), 17, 5, (327-332), 10.1111/j.1755-5949.2011.00265.x);Deficiency of NG2+ Cells Contributes to the Susceptibility of Stroke-Prone Spontaneously Hypertensive Rats

CNS Neuroscience and Therapeutics

Volumn 17, Issue 5, 2011, Pages 327-332

  Wang, Pei ^a   Tian, Wei Wei ^a   Song, Jie ^a   Guan, Yun Feng ^a   Miao, Chao Yu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Demyelination; Oligodendrocyte; SHR SP; Stroke

Indexed keywords

MYELIN BASIC PROTEIN; PROTEOCHONDROITIN SULFATE; PROTEOCHONDROITIN SULFATE NG2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN REGION; C57BL 6 MOUSE; CELL COUNT; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; RAT; STROKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

EID: 80053198889     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.13292     Document Type: Erratum

References (46)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-1623.
2. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-1134.
3. Bazzano LA, Gu D, Whelton MR, et al. Body mass index and risk of stroke among Chinese men and women. Ann Neurol 2010;67:11-20.
4. Kurth T, Leitzmann MF. Awakening of the sleeping giant: obesity and stroke in China. Ann Neurol 2010;67:1-2.
5. Zhu X, Bergles DE, Nishiyama A. NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 2008;135:145-157.
6. Belachew S, Chittajallu R, Aguirre AA, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003;161:169-186.
7. Richardson WD, Young KM, Tripathi RB, McKenzie I. NG2-glia as multipotent neural stem cells: Fact or fantasy Neuron 2011;70:661-673.
8. Tanaka K, Nogawa S, Ito D, et al. Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain. Neuroreport 2001;12:2169-2174.
9. Komitova M, Perfilieva E, Mattsson B, Eriksson PS, Johansson BB. Enriched environment after focal cortical ischemia enhances the generation of astroglia and NG2 positive polydendrocytes in adult rat neocortex. Exp Neurol 2006;199:113-121.
10. Smirkin A, Matsumoto H, Takahashi H, et al. Iba1+/NG2+ macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cerebr Blood F Met 2011;30:603-615.
11. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006;24:1125-1135.
12. Paschen W, Mies G, Bodsch W, Yamori Y, Hossmann KA. Regional cerebral blood flow, glucose metabolism, protein synthesis, serum protein extravasation, and content of biochemical substrates in stroke-prone spontaneously hypertensive rats. Stroke 1985;16:841-845.
13. Wang P, Xu TY, Guan YF, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 2011;69:360-374.
14. Speidl WS, Cimmino G, Ibanez B, et al. Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. Eur Heart J 2010;31:2049-2057.
15. Harrington EP, Zhao C, Fancy SPJ, Kaing S, Franklin RJM, Rowitch DH. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol 2010;68:703-716.
16. Voermans NC, van Alfen N, Pillen S, et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009;65:687-697.
17. Wang P, Yang FJ, Du H, et al. Involvement of leptin receptor (LepRb)-STAT3 signaling pathway in brain FTO downregulation during energy restriction. Mol Med 2011;17:523-532.
18. Venteo L, Bourlet T, Renois F, et al. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J 2010;31:728-736.
19. Nyakas C, Felszeghy K, Szabó R, et al. Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on nmda-induced neurotoxicity in a rat entorhinal cortex lesion model. CNS Neuroscience & Therapeutics 2009;15:89-99.
20. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 2010;67:41-52.
21. Yager JY, Thornhill JA. The effect of age on susceptibility to hypoxic-ischemic brain damage. Neurosci Biobehav Rev 1997;21:167-174.
22. Sánchez MG, Bourque M, Morissette M, Di Paolo T. Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders. CNS Neuroscience & Therapeutics 2010;16:e43-e71.
23. Jickling GC, Xu H, Stamova B, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol 2010;68:681-692.
24. Guo JM, Liu AJ, Su DF. Genetics of stroke. Acta Pharmacol Sin 2010;31:1055-1064.
25. Vilela P, Goulao A. Ischemic stroke: Carotid and vertebral artery disease. Eur Radiol 2005;15:427-433.
26. Matter CM, Stuber M, Nahrendorf M. Imaging of the unstable plaque: How far have we got? Eur Heart J 2009;30:2566-2574.
27. Andersen ZJ, Olsen TS, Andersen KK, Loft S, Ketzel M, Raaschou-Nielsen O. Association between short-term exposure to ultrafine particles and hospital admissions for stroke in Copenhagen, Denmark. Eur Heart J 2010;31:2034-2040.
28. Qureshi AI, Feldmann E, Gomez CR, et al. Intracranial atherosclerotic disease: An update. Ann Neurol 2009;66:730-738.
29. Klingenberg R, Hansson GK. Treating inflammation in atherosclerotic cardiovascular disease: Emerging therapies. Eur Heart J 2009;30:2838-2844.
30. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010;31:967-975.
31. Lubitz SA, Rosen AB, Ellinor PT, Benjamin EJ. Stroke risk in AF: Do AF patterns matter? Eur Heart J 2010;31:908-910.
32. Lip GY, Rasmussen LH, Olsson SB, et al. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. Eur Heart J 2009;30:2897-2907.
33. Putaala J, Haapaniemi E, Metso AJ, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol 2010;68:661-671.
34. Seok JM, Kim SG, Kim JW, et al. Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 2010;68:213-219.
35. Basu A, Graziadio S, Smith M, Clowry GJ, Cioni G, Eyre JA. Developmental plasticity connects visual cortex to motoneurons after stroke. Ann Neurol 2010;67:132-136.
36. Shiue I. Does body mass index increase risk of hemorrhagic stroke? Ann Neurol 2010;68:115-116; author reply 116.
37. Johnston SC, Sidney S, Hills NK, et al. Standardized discharge orders after stroke: Results of the quality improvement in stroke prevention (QUISP) cluster randomized trial. Ann Neurol 2010;67:579-589.
38. Cheung N, Liew G, Lindley RI, et al. Retinal fractals and acute lacunar stroke. Ann Neurol 2010;68:107-111.
39. Putaala J, Haapaniemi E, Metso AJ, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke. Ann Neurol 2010;68:661-671.
40. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex: A novel target for preventing stroke in rat hypertension. Stroke 2007;38:1916-1923.
41. Ghisdal P, Godfraind T, Morel N. Effect of nitro-L-arginine on electrical and mechanical responses to acetylcholine in the superior mesenteric artery from stroke-prone hypertensive rat. Br J Pharmacol 1999;128:1513-1523.
42. Jesmin S, Sakuma I, Togashi H, et al. Altered expression of endothelin and its receptors in the brain of SHR-SP at malignant hypertensive stage. J Cardiovasc Pharmacol 2004; 44 (Suppl 1):S11-S15.
43. Lippoldt A, Kniesel U, Liebner S, et al. Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res 2000;885:251-261.
44. Nagotani S, Hayashi T, Sato K, et al. Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress. Stroke 2005;36:670-672.
45. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 2003;23:263-274.
46. Torkildsen O, Brunborg LA, Myhr KM, Bo L. The cuprizone model for demyelination. Acta Neurol Scand Suppl 2008;188:72-76.